Gedske Daugaard

professor

Rigshospitalet

Denmark

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gedske Daugaard is a professor at Rigshospitalet in Denmark. His research focuses on testicular cancer,including areas such as relapse detection, paternity outcomes, and the impact of testosterone replacement therapy on cancer survivors. Recent articles authored by him explore innovative biomarkers, predictive outcomes for patients, and the evaluation of adjuvant therapy versus surveillance strategies.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Lise Aksglaede

Copenhagen University Hospital

DENMARK

View details

Jakob Lauritsen

Copenhagen University Hospital

DENMARK

View details

Anders Juul

DENMARK

View details

Sara Ludovico Garcia

Københavns Universitet

DENMARK

View details

Rikke Linnemann Nielsen

DENMARK

View details

Mads Agerbaek

Aarhus University

DENMARK

View details

Kristian Almstrup

DENMARK

View details

N Jørgensen

DENMARK

View details

Mikkel Heide Schierup

Professor

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gedske Daugaard

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide study

Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors

Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy

Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial

The seminal plasma microbiome of men with testicular germ cell tumours described by small RNA sequencing

Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study

Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy

Small RNAs in Seminal Plasma as Novel Biomarkers for Germ Cell Tumors

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

Late adverse effects and quality of life in survivors of testicular germ cell tumour

Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients

Collaborators (9)

Lise Aksglaede

Jakob Lauritsen

Anders Juul

Sara Ludovico Garcia

Rikke Linnemann Nielsen

Mads Agerbaek

Kristian Almstrup

N Jørgensen

Mikkel Heide Schierup

Make your next move.